15 RI Companies Get $4.8M in Biotech Grants

Email to a friend Permalink

Friday, November 05, 2010

GoLocalProv News Team

Fifteen Rhode Island bioscience companies have received $4.8 million in federal funds and credits, the Tech Collective announced yesterday.

The money, provided through the Affordable Care Act, will fund 23 research projects. The goal of the projects is to develop innovative and affordable new therapies.

Overall $1 billion in federal funds were distributed to nearly 3,000 small biotech companies across the country. The Secretary of the Treasury, Secretary of Health and Human Services, the National Institutes of Health announced the funds yesterday.

“The United States has the most innovative companies, the most ambitious entrepreneurs and the most productive workers in the world,” said Treasury Secretary Tim Geithner. “These grants will help make sure our companies, entrepreneurs and workers can continue to invest and innovate, which will strengthen our economy now and far into the future.”

Rhode Island Recipients
• BCR Diagnostics, Inc.
• Calmar Pain Relief, LLC
• Collegium Pharmaceutical, Inc.
• EpiVax, Inc.
• IlluminOss Medical, Inc.
• InCytu, Inc.
• ISIS BIOPOLYMER, Inc.
• MultiCell Technologies, Inc.
• MYOMICS, Inc.
• NABsys, Inc.
• Neurotech USA, Inc.
• PROTHERA BIOLOGICS, LLC
• Rhode Island Mood & Memory Research Institute
• Tivorsan Pharmaceuticals, Inc.
 

Enjoy this post? Share it with others.

Email to a friend Permalink